近十年来国内外再生医学创新型医疗技术产业显示出了巨大的潜力和发展前景。本文通过查阅、整理和分析美国、欧盟成员国、日本、澳大利亚等典型发达国家在细胞技术类再生医学创新型医疗技术产业的现状和相关的政策法规、管理机制及其面临的问题，研究了我国在该技术产业的发展现状和政府的监管政策及管理机制，分析和总结了该产业的发展趋势、特点和存在的问题，提出以大力发展我国细胞技术类再生医学创新型医疗技术产业为原则，以突破产业发展的瓶颈为出发点的系列专家建议和意见。

The innovative medical technology industry of regenerative medicine has shown huge economic potential and development prospects both at home and abroad in the last decade. After describing the current situation of industrial development in innovative technology in cell-technology-related regenerative medicine, we investigate, sort, and analyze related policies and regulations, management systems, and existing problems in the United States, the European Union, Japan, Australia, and other developed countries. On this basis, we study the current development situation, governmental regulation policies, and management mechanism of this industry in China. Next, we analyze and summarize the industry development trend, characteristics, and existing problems. Finally, based on experts’ advice and opinions on breaking through the bottleneck of industrial development, we suggest that it is imperative for us to strive to develop the innovative technology industry of cell-technology-related regenerative medicine in China.